Evaluation of CG-100 Intraluminal Bypass Device

Colospan

Status: Enrolling

Conditions: Colorectal Cancer

Treatments: Device: CG-100 Intraluminal Bypass Device

Study type: Interventional

Funder types: Industry

Identifiers

NCT05632744

CLD-113

Details and patient eligibility

About

Evaluation of CG-100 Intraluminal Bypass device

Enrollment: 10 estimated patients

Sex: All

Ages: 22 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria (pre-operative):

1. Willing to comply with protocol-specified follow-up evaluations
2. 22-75 (inclusive) years of age at screening
3. Diagnosed with colorectal cancer
4. Has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

CG-100 Intraluminal Bypass Device

Experimental group

Description:

Subjects will be treated with CG-100 Intraluminal Bypass Device

Treatment:

Device: CG-100 Intraluminal Bypass Device